Article info
PDFClinical and epidemiological research
Extended report
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
- Correspondence to Philip J Mease, Department of Rheumatology, Seattle Rheumatology Associates, 1101 Madison Street Ste 1000, Seattle 98104, Washington, USA; pmease{at}nwlink.com
Citation
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
Publication history
- Received November 16, 2011
- Accepted December 11, 2011
- First published February 10, 2012.
Online issue publication
June 13, 2012
Article Versions
- Previous version (10 February 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions